Ryan
Clarkson

Artificial Intelligence Cases – Mr. Clarkson is leading the charge globally against some of the largest corporations in the world for their use of volatile and inaccurate artificial intelligence tools in healthcare, technology, and other sectors.

Fluoroquinolone Antibiotic Cases – Mr. Clarkson was the first plaintiff attorney in the country to represent clients in connection with permanent and disabling nerve damage caused by Levaquin, Cipro, and Avelox manufactured by Johnson & Johnson and Bayer Pharmaceuticals. Mr. Clarkson represents dozens of clients across the country.

Kandel, et al. v. Dr. Dennis Gross Skincare, LLC, Case No. 1:23-cv-01967-ER (S.D.N.Y. 2024) – Clarkson served as Class Counsel in a case involving false labeling claims against a major skincare brand. The firm secured final approval of a $9.2 million settlement on behalf of a nationwide class, ensuring restitution for consumers misled by deceptive product representations.

Gunaratna, et al. v. Dr. Dennis Gross Skincare, LLC, Case No. 2:20-cv-02311-MWF-GJS – False, misleading, deceptive labeling and advertisement of products as containing “Collagen” when in fact the products did not contain collagen at all. Class certification granted and appointment of Clarkson Law Firm as Class Counsel by the Hon. Michael W. Fitzgerald on April 4, 2023.

Hezi, et al. v. Celsius Holdings, Inc., Case No. 1:21-cv-09892-JHR (S.D.N.Y) – False labeling and advertisement of products as having “No Preservatives.” Final approval of $7.8 million nationwide settlement class was granted by Hon. Jennifer H. Rearden on April 5, 2023.

Heath, et al. v. Keenan & Associates, No. 24STCV03018 (Super. Ct. L.A. County, Feb. 2, 2024) – Clarkson filed a class action against Keenan & Associates in response to a data breach exposing sensitive financial and medical records. The firm aims to secure accountability and compensation for victims impacted by the mishandling of highly confidential information.

Swetz v. GSK Consumer Health, 2021 U.S. Dist. LEXIS 227208 (S.D.N.Y. Nov. 22, 2021) – Clarkson represented consumers in a false labeling action over products promoted as “100% Natural” and “Clinically proven to curb cravings.” Acting as Class Counsel, the firm secured a $6.5 million nationwide settlement approved by the court, addressing misleading health claims in advertising.

Thomas v. Nestle USA, Inc., Los Angeles Superior Court, Case No. BC649863, 2020 Cal. Super. LEXIS 45291 – Unlawful and deceptive packaging of box candy. Class certification granted and appointment of Clarkson Law Firm as Class Counsel by Hon. Daniel J. Buckley on April 29, 2020. Final approval of $3.7 million nationwide class granted by Hon. Daniel J. Buckley on January 14, 2022.

Prescott v. Bayer Healthcare, LLC, Case No. 20-cv-00102-NC (N.D. Cal.) – In a class action concerning the false advertisement of products as “Mineral-based,” Clarkson was appointed Class Counsel and achieved final approval of a $2.25 million nationwide settlement. The case reinforces the firm’s commitment to corporate accountability in consumer marketing.

Garcia v. Iovate et al., Santa Barbara Sup. Ct., Case No. 1402915 – Mr. Clarkson successfully intervened in this case on behalf of a class of consumers of the popular “Hydroxycut” weight loss supplement. Mr. Clarkson and co-counsel increased the size of the settlement by more than ten-fold to a total court-approved settlement value of $10 million.

Morales, et al vs. Kraft Foods Group, Inc., CACD Case No. 2:14-cv- 04387-JAK-PJW. – Mr. Clarkson served as lead class counsel in a California certified class action lawsuit against the world’s second largest food and beverage company for false advertising and mislabeling of food product as “natural.”